![JW Lifescience Corporation logo](/logos/234080.KS.webp)
JW Lifescience Corporation
KRX:234080.KS
Overview | Financials
Company Name | JW Lifescience Corporation |
Symbol | 234080.KS |
Currency | KRW |
Price | 11,900 |
Market Cap | 184,266,740,000 |
Dividend Yield | 4.02% |
52-week-range | 11,670 - 15,160 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Sungnam Cha |
Website | https://www.jw-lifescience.co.kr |
An error occurred while fetching data.
About JW Lifescience Corporation
JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD